Skip to main content
Figure 5 | BMC Cancer

Figure 5

From: Qualitative analysis of Adenomatous Polyposis Coli promoter: Hypermethylation, engagement and effects on survival of patients with esophageal cancer in a high risk region of the world, a potential molecular marker

Figure 5

MSP results of two positive controls. Lane 1; MSP product of universally methylated DNA by applying methylated cytosine specific primers. Lane 2; the same as lane 1 but unmethylated cytosine specific primers were used. lane 3; MSP product of blood DNA extracted from a healthy donor treated with DNA methylase (CpG methyl transferase) and application of methylated cytosine specific primers, lane 4; the same as lane 3 but unmethylated cytosine specific primers were used.

Back to article page